Urinary Excretion of Acetylamantadine by Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

June 30, 2008

Study Completion Date

July 31, 2008

Conditions
Cancer
Interventions
DRUG

Ingestion of a 200 mg dose of amantadine hydrochloride

Volunteer cancer patients ingest 2 x 100 mg tablets of amantadine hydrochloride with a glass of cold water 2 hours after supper.

DRUG

Ingestion of a 200 mg dose of amantadine hydrochloride

Healthy subject ingests 2 x 100 mg tablets of amantadine hydrochloride with a glass of cold water 2 hours after supper

Trial Locations (1)

R3E 0W3

University of Manitoba, Winnipeg

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

BioMark Technologies Inc.

INDUSTRY

lead

University of Manitoba

OTHER